Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $49,891 - $57,731
-310 Reduced 33.88%
605 $104,000
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $735,255 - $884,551
-5,054 Reduced 84.67%
915 $152,000
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $748,022 - $898,208
5,704 Added 2152.45%
5,969 $875,000
Q3 2022

Nov 02, 2022

SELL
$148.29 - $182.55 $106,768 - $131,436
-720 Reduced 73.1%
265 $39,000
Q2 2022

Aug 02, 2022

BUY
$155.97 - $200.09 $123,372 - $158,271
791 Added 407.73%
985 $169,000
Q1 2022

May 11, 2022

BUY
$181.39 - $234.03 $35,189 - $45,401
194 New
194 $37,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.